exRNAdisease

Entry Detail

---



General Information

Database ID: exR0763184 RNA Name: RPS2 RNA Type: mRNA Chromosome: chr16 Starnd: - Coordinate: Start Site(bp): 1962058 End Site(bp): 1964841 External Links: ENSG00000140988

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AC087289.3 chr17 75898645 75930129 - ADSL chr22 40346500 40390463 + ACTR3 chr2 113890063 113962596 + ADPRH chr3 119579268 119589945 + ADAR chr1 154582057 154628013 - AC138811.2 chr16 18788063 18801519 - ALDOA chr16 30064164 30070457 + AHCY chr20 34280268 34311802 - AL133352.1 chr10 100505628 100529881 - AC093525.2 chr16 2496032 2520218 + AC007192.1 chr19 18153158 18178117 + AL590764.2 chrX 71103987 71111575 - AC004832.3 chr22 30409255 30428990 + AL669918.1 chr6 32813767 32838822 - AC024592.3 chr19 5866171 5903787 - AC010422.3 chr19 12643831 12648397 - AL136295.1 chr14 24189157 24213473 - ADGRG5 chr16 57542643 57591681 + ADGRB1 chr8 142449430 142545009 + AL021546.1 chr12 120438198 120460006 + AC093525.1 chr16 2513965 2527955 + AL022238.4 chr22 40346529 40410054 + AGAP4 chr10 45825594 45853875 - AC092143.1 chr16 89919165 89936092 + AC015813.2 chr17 57989038 58007246 - AC107871.1 chr15 68184032 68229718 - AGAP3 chr7 151085831 151144436 + AL603832.3 chr1 112702614 112711433 - ACTG1 chr17 81509971 81523847 - AC069503.2 chr12 121888809 121921470 + miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-1244 chr2 231713368 231713393 + hsa-miR-7111-3p chr6 35470558 35470579 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC007952.4 chr17 19112000 19112636 - AC010542.4 chr16 66549280 66551189 + AC087190.3 chr16 9104848 9113181 + AC087521.3 chr11 43921059 44001157 + AC108134.2 chr16 3156736 3157483 - AC245033.4 chr15 82533175 82540008 - AD000090.1 chr19 35557956 35581954 + AL022311.1 chr22 37876148 37895563 + Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.